Heinz Lubenau

Heinz Lubenau

Company: NEC OncoImmunity

Job title: Chief Drug Development Officer

Seminars:

Employing Oral Bacteria-Based DNA Vaccine Targeting Neoantigens 11:30 am

Identifying neoantigen-specific immune responses Highlighting the benefits of oral administration Implementing a comprehensive set of biomarkers in checkpoint inhibitor combination studies to assess the neoantigen-treatment-related effectRead more

day: Conference Day One

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.